A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
|Articles|October 30, 2017
- October 2017 Diabetes
- Volume 83
- Issue 10
Can You Read These Rxs? (October 2017)
Can you figure out what these prescriptions say?
Advertisement
Send in your eye-straining, baffling prescriptions—now via e-mail and fax as well as regular mail! Submissions must include a clean photocopy or scanned image of the Rx; your institution’s name and location; your name and title; the correct name of the drug(s), strength, and dosing requirements; and your phone number. You can e-mail scanned Rxs to rmarotta@pharmacytimes.com; fax them to 609-257-0701; or mail them to Can You Read These Rxs?, Pharmacy Times, 2 Clarke Drive, Suite 100, Cranbury, NJ 08512.
Articles in this issue
almost 9 years ago
Case Studies (October 2017)almost 9 years ago
Pet Peeves (October 2017)almost 9 years ago
Rx Product News (October 2017)almost 9 years ago
Ingrezzaalmost 9 years ago
OTC Product News (October 2017)almost 9 years ago
Self-Care for Diabetesalmost 9 years ago
Are Fad Diets Just a Fad?almost 9 years ago
Does an Employee Have Access to Her PDMP Database Records?almost 9 years ago
Who Is to Blame for the Opioid Crisis?almost 9 years ago
Vaccine Abbreviations and Acronyms Contribute to ErrorsAdvertisement
Related to this article
Understanding local health care priorities is essential to developing meaningful solutions.
Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.
Mounjaro becomes the first GIP/GLP-1 receptor agonist cleared to lower MACE risk, based on the SURPASS-CVOT head-to-head trial.
Two recent graduates share strategies for standing out in the competitive fellowship application process.
Community pharmacies are access points, safe places, and sources of stability when everything else feels uncertain.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
2
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
3
Kidney Week 2026: What to Know for Nephrology's Biggest Meeting
4
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
5